AI could make ovarian cancer surgery safer by guiding fluids and blood pressure
NCT ID NCT07070973
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This pilot study tests whether an AI-based system can help doctors better manage fluids and blood pressure during complex ovarian cancer surgery. The system uses special software to guide fluid infusions and predict drops in blood pressure. The goal is to reduce complications like kidney injury and fluid overload. The study will compare results from 52 patients to a historical group of 50 patients who received standard care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Assisted Fluid Management software and Hypotension Prediction Index
What this could lead to
If successful, this could lead to a safer way to manage fluids and blood pressure during complex ovarian cancer surgery, potentially reducing complications like kidney injury and fluid overload.
What could go wrong
This is a small pilot study (52 participants) comparing results to past patients, not a large randomized trial. The AI tools may not improve outcomes as expected, and results may not apply to all hospitals or patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVARIAN CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
IRCCS Fondazione Policlinico A. Gemelli
RECRUITINGRome, 00167, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact